Inventor · disambiguated record
Michael Charles Hewitt
Also filed as: HEWITT MICHAEL C · HEWITT MICHAEL CHARLES
33 granted patents·9 pending applications·205 citations·filing 2002–2024
96Inventor score
Files withSUNOVION PHARMACEUTICALS INC19CONSTELLATION PHARMACEUTICALS INC4GENENTECH INC4SHAO LIMING4ALBRECHT BRIAN K3
Top patents by PatentIndex Score
42 records- 0197US9249161B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Feb 2, 2016·50 cites·12 claims
- 0295US10894033B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·3 cites·21 claims
- 0395US8710245B2Multicyclic compounds and methods of use thereofSHAO LIMING·Filed 2010·Granted Apr 29, 2014·32 cites·41 claims
- 0492US8796261B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Aug 5, 2014·21 cites·28 claims
- 0591US10085968B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·7 cites·60 claims
- 0691US9351954B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·10 cites·37 claims
- 0791US8053603B2Tetralone-based monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2006·Granted Nov 8, 2011·24 cites·23 claims
- 0887US9522920B2Bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Dec 20, 2016·10 cites·21 claims
- 0987US9249162B2Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·7 cites·27 claims
- 1086US10562916B2Substituted quinoxalines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·4 cites·24 claims
- 1186US9422292B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2012·Granted Aug 23, 2016·5 cites·17 claims
- 1286US8969349B2Substituted quinoxalines and quinoxalinones as PDE-10 inhibitorsCAMPBELL JOHN EMMERSON·Filed 2011·Granted Mar 3, 2015·10 cites·25 claims
- 1385US2024358675A1Multicyclic compounds and methods of use thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 1483US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 1580US2022387382A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1679US10183009B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jan 22, 2019·3 cites·22 claims
- 1778US9133117B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Sep 15, 2015·2 cites·21 claims
- 1878US8765760B2[1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterasesCAMPBELL JOHN EMMERSON·Filed 2012·Granted Jul 1, 2014·3 cites·22 claims
- 1978US8592608B2Triple reuptake inhibitors and methods of their useSHAO LIMING·Filed 2009·Granted Nov 26, 2013·2 cites·25 claims
- 2077US8669291B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2008·Granted Mar 11, 2014·2 cites·19 claims
- 2175US2021267938A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2273US9925197B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·1 cites·5 claims
- 2372US9493483B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·1 cites·8 claims
- 2469US8877975B2Cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2010·Granted Nov 4, 2014·1 cites·23 claims
- 2568US10150767B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 11, 2018·1 cites·14 claims
- 2668US2019125722A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2766US9586888B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·0 cites·27 claims
- 2865US9868718B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·0 cites·2 claims
- 2964US7943594B2Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycansMASSACHUSETTS INST TECHNOLOGY·Filed 2003·Granted May 17, 2011·1 cites·18 claims
- 3063US10428021B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·0 cites·11 claims
- 3163US2017204050A1Phenyl substituted cycloalkylamines as monoamine reputake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3261US10570156B2Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 25, 2020·0 cites·18 claims
- 3360US2007203111A1Cycloalkylamines as monoamine reuptake inhibitorsSEPRACOR INC·Filed 2007·Application pending·0 cites
- 3457US10562878B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·0 cites·26 claims
- 3556US9856274B2Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jan 2, 2018·0 cites·28 claims
- 3655US9850204B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Dec 26, 2017·0 cites·23 claims
- 3752US10457640B2Synthesis of inhibitors of EZH2CONSTELLATION PHARMACEUTICALS INC·Filed 2017·Granted Oct 29, 2019·0 cites·20 claims
- 3851US2022267323A1Synthesis of bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Application pending·0 cites
- 3951US2003232978A1Reagents that facilitate the purification of compounds synthesized on a solid supportFiled 2002·Application pending·0 cites
- 4048US9834564B2Substituted quinolines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·0 cites·32 claims
- 4146US2012003260A1Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol GlycansSEEBERGER PETER H·Filed 2011·Application pending·0 cites
- 4240US10258603B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Apr 16, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Michael Charles Hewitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →